UNSPSC 51281675: Streptomycin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula 2C21H39N7O12.3H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CW25IKJ202, chemically known as streptomycin, sulfate (2:3) (salt) but more generally known as streptomycin sulfate, which bears US NIH Compound Identifier 19648. European Medicines Agency schedules Streptomycin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04593MIG.

Most nations, for tariff and trade purposes, schedule streptomycin sulfate under HS 29412080 and SITC 54132. Streptomycin sulfate bears US NLM identifiers UMLS ID C0038426 and NCI Concept Code C47729. SMILES: As of Q4 2014, STREPTOMYCIN SULFATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281675 Streptomycin sulfate is a Commodity code for pharmaceutical active ingredients and finished formulations, but the recent state and local opportunities tagged under it show no actual procurement of streptomycin. Instead, the code has been applied to unrelated pharmaceutical products—antibiotic tablets (doxycycline, ciprofloxacin) and public-health supplies (naloxone, drug deactivation systems)—reflecting a classification mismatch in state and local procurement systems. Issuing bodies using the code include state health departments and county public-health agencies.

The code shows minimal relevant recent activity. The Illinois Department of Public Health awarded a completed piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for doxycycline hyclate and ciprofloxacin, totaling $2,999,999.11 over three years including renewals. Seminole County, Florida issued an IFB in June 2026 for naloxone and safe drug deactivation systems—1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. Neither opportunity actually solicited streptomycin or products meaningfully aligned with the code's nominal scope. Geographic activity concentrates in Illinois and Florida based on these two records, though the classification misalignment suggests the code does not reliably track streptomycin procurement at the state and local level.